؊/؊ ) mice infected with virulent Brucella abortus 2308 at 5 ؋ 10 5 CFU developed acute hepatitis similar to many natural hosts but, unlike natural hosts, IRF-1 ؊/؊ mice were unable to resolve infection and died. In contrast, IRF-1 ؊/؊ mice survived when infected at 5 ؋ 10 5 CFU with several attenuated Brucella strains (S19, RB51, cbp, and cyd). The survival of infected IRF-1 ؊/؊ mice is likely a function of the level of virulence of each Brucella strain and the extent of retained immunity. Further, these findings suggest that adaptive immunity may be important to the survival of IRF-1 ؊/؊ mice since attenuated Brucella strains can protect IRF-1 ؊/؊ mice against lethal challenge with virulent Brucella. Using the IRF-1
Brucella abortus, a gram-negative facultative intracellular bacterium, is the etiologic agent of zoonotic brucellosis, whose pathologic manifestations are hepatitis, arthritis, endocarditis, and meningitis in humans and spontaneous abortion in cattle, respectively (4, 7, 17) . This airborne pathogen resides and multiplies in macrophages of mammalian hosts and has been used as a model to study immune response against intracellular bacteria, as well as to investigate the mechanisms of intracellular bacterial pathogenesis (25, 26, 27) . Brucella virulence is determined by infecting mice with various Brucella strains and sequentially monitoring bacterial clearance from selected organs, usually the liver and spleen (6, 9, 15a, 28) .
Gamma interferon (IFN-␥) is a crucial cytokine in Brucella immunity required for macrophage bactericidal activity (2) . In general, the diverse functions of IFN-␥ are mediated by interferon regulatory factors (IRFs), a family of secondary transcriptional factors (18, 29) . This family, which includes IRF-1 through IRF-8 and p48, is characterized by the unique "tryptophan cluster" DNA-binding region located at the N terminus. IRF-1 is strongly inducible by IFN-␣/␤ and IFN-␥, as well as by tumor necrosis factor alpha (TNF-␣), and participates in many IFN-specific signaling pathways. The immunobiology of IRF-1 is elucidated by IRF-1 Ϫ/Ϫ mice. These mice are characterized by a 90% reduction of CD8 ϩ T cells, functionally impaired natual killer (NK) cells, and dysregulation of interleukin-12 (IL-12) p40 and inducible nitric oxide synthase (iNOS) induction, which are necessary to confer proper immune protection. Thus, this mouse strain is useful for understanding the roles of IRF-1 during in vivo bacterial infections.
The clearance of Brucella from host tissues is often examined for at least 6 weeks because of the chronic nature of brucellosis, and highly virulent strains can persist for at least 20 weeks (26) . Further, the chronic nature of Brucella infection in mice parallels the chronic nature of human infection (3, 20) . However, determining the virulence of several Brucella strains based on the time of clearance from organs creates a formidable labor-intensive challenge. Therefore, animal models that would provide a rapid measure of Brucella virulence are needed. Previously, we reported that IRF-1 Ϫ/Ϫ mice infected with 5 ϫ 10 5 CFU of virulent B. abortus S2308 died from severe hepatic damage within 2 weeks postinfection, whereas RB51-infected mice survived (Ko et al., unpublished) , implying a significant role for IRF-1 in Brucella immunity in vivo. However, the survival of IRF-1 Ϫ/Ϫ mice infected with 5 ϫ 10 5 CFU of the attenuated RB51 strain suggests that a certain level of Brucella virulence is required to induce the death of IRF-1
Ϫ/Ϫ mice appear to have a level of basal immunity necessary to control the infection.
No human vaccine exists against Brucella, and methods are necessary to dissect Brucella pathogenesis to reach this vaccine goal. A number of Brucella strains have been identified, but readily available criteria to rapidly distinguish and rank the level of virulence among Brucella strains are needed. Thus, the rapid death of IRF-1 Ϫ/Ϫ mice infected with virulent Brucella, in contrast to the survival of IRF-1 Ϫ/Ϫ mice infected with an attenuated Brucella strain, suggests that IRF-1 Ϫ/Ϫ mice, as an animal model, could be useful for detecting various degrees of Brucella virulence. Here we have utilized the IRF-1 Ϫ/Ϫ mouse to define the level of virulence of various Brucella strains.
The aim of the present study was to investigate both wild-type and mutant Brucella strains for virulence and thus define the criteria for Brucella virulence. We also found that immunologic memory can provide protection to IRF-1 Ϫ/Ϫ mice. Here we report that the criteria of Brucella virulence among several strains is based on the following factors: (i) the rapidity of death in IRF-1 Ϫ/Ϫ mice infected with Brucella at 5 ϫ 10 5 CFU, (ii) the extent of hepatic damage, and (iii) the protection against Brucella virulence provided by immunizing IRF-1
mice with an attenuated strain that induces an adaptive immune response. The varying responses of IRF-1 Ϫ/Ϫ mice against diverse Brucella strains as a function of different levels of virulence suggests the importance of this mouse, as an animal model, for dissecting bacterial pathogenesis by using attenuated, gene-disrupted bacteria. In so doing, the immunobiology of IRF-1 Ϫ/Ϫ mice will be clarified, thus increasing the value of the mouse strain as an animal model.
RESULTS

Survival of IRF-1
؊/؊ mice infected with different CFU counts of B. abortus S2308, S19, and RB51. Previously, we reported that IRF-1 Ϫ/Ϫ mice respond to Brucella infection in a death or survival manner, depending on the levels of virulence among injected strains at 5 ϫ 10 5 CFU (15a). This result suggested that a certain level of virulence is required to induce death in IRF-1 Ϫ/Ϫ mice and/or the basal immunity of IRF-1 Ϫ/Ϫ mice can control the infection caused by an attenuated strain. Thus, to establish criteria to determine virulence, the response of IRF-1 Ϫ/Ϫ mice infected with selected doses of B. abortus strains possessing different levels of virulence was investigated, and the results are summarized in Table 1 . The response of IRF-1
Ϫ/Ϫ mice was tested with three different B. abortus strains; wild-type strain S2308, the previous vaccine strain S19, and the current vaccine strain RB51. The differences in the virulence of these three strains have been well elucidated in mice, and the apparent order of virulence is as follows: S2308 Ͼ S19 Ͼ RB51 (2, 28) .
Fifty percent of IRF-1 Ϫ/Ϫ mice injected with S2308 and S19 at 5 ϫ 10 5 CFU died at 10 and 20 days postinoculation, respectively, whereas IRF-1 Ϫ/Ϫ mice injected with the same dose of RB51 survived the 4 weeks of infection (Fig. 1) . Thus, the life or death of the host induced by 5 ϫ 10 5 CFU was dependent on Brucella virulence. Similarly, S2308 and S19 at 5 ϫ 10 7 CFU produced death of 50% of IRF-1 Ϫ/Ϫ mice between 6 to 7 days postinoculation, whereas the injection of the same CFU of RB51 failed to induce death of IRF-1 Ϫ/Ϫ mice during the 4 weeks of infection (data not tabulated). All IRF-1 Ϫ/Ϫ mice injected with 5 ϫ 10 9 CFU of RB51 died 7 days later (data not tabulated). In contrast, IRF-1 Ϫ/Ϫ mice injected with 5 ϫ 10 1 or 5 ϫ 10 3 CFU of S2308 and S19 survived infection (data not tabulated). Similarly, S2308 and S19 at 5 ϫ 10 7 and RB51 at 5 ϫ 10 9 CFU did not cause death of IRF-1 ϩ/ϩ mice (n ϭ 3 per group) during the 4 weeks of infection (data not tabulated). Taken together, the death or survival of IRF-1 Ϫ/Ϫ mice caused by respective doses of Brucella is a unique feature that may be related to the importance of the IRF-1 transcription factor in activating critical host protective mechanisms (19, 24) . Also, these results indicate that the rapidity of death or the survival of IRF-1 Ϫ/Ϫ mice is dependent on the dose and virulence of respective Brucella strains, and the injection of 5 ϫ 10 5 CFU in IRF-1 Ϫ/Ϫ mice can be an optimal bacterial concentration to differentiate the level of virulence in B. abortus strains. In fact, no RB51 (5 ϫ 10 5 CFU)-infected mice died during the study, and 50% of S2308 infected mice were dead by day 10. The differences in the day postinfection when 50% of IRF-1 Ϫ/Ϫ mice were dead could be a useful indicator to identify the degree of virulence ( Table 1) .
Enumeration of B. abortus CFU from liver and spleen of S2308, S19, and RB51 infected IRF-1 ؉/؉ and IRF-1 ؊/؊ mice. To correlate the level of virulence in B. abortus strains S2308, S19, and RB51 with the outcome of infection, IRF-1 ϩ/ϩ mice were infected with 5 ϫ 10 5 CFU, and splenic Brucella CFU counts were determined for 4 weeks. Infected IRF-1 ϩ/ϩ mice had similar numbers of S2308 and S19 Brucella CFU during the 4 weeks of infection, although a statistically significant (P Ͻ 0.05) 1-log-higher amount of S19 was detected at 2 weeks postinoculation ( Fig. 2) . In contrast, RB51-infected IRF-1 ϩ/ϩ mice contained a 3-log-lower bacterial CFU in the spleen compared to S2308 and S19 infected mice after the first week of infection. In subsequent weeks, RB51 colonies were difficult to identify (Fig. 2) .
IRF-1 Ϫ/Ϫ mice infected with virulent S2308 maintained a 1-log-greater bacterial CFU compared to infected IRF-1 ϩ/ϩ mice for the first 9 days, Fig. 3A . However, a 2-log difference in bacteria at day 12 was observed between IRF-1 Ϫ/Ϫ and IRF-1 ϩ/ϩ mice in the liver (Fig. 3A) but not in the spleen (Fig.  3B ). In contrast, IRF-1 Ϫ/Ϫ and IRF-1 ϩ/ϩ mice infected with attenuated RB51 had a similar pattern of hepatic bacterial clearance, except that clearance in IRF-1 Ϫ/Ϫ mice was delayed until day 12.
Clearance of attenuated RB51 from the spleens of IRF-1
mice was more effective than clearance of virulent S2308 that persisted for the 12 days of infection. However, IRF-1 Ϫ/Ϫ mice maintained RB51 at 3.5 to 4 log CFU in the spleen for the 12 days postinfection compared to the rapid reduction of bacteria in IRF-1 ϩ/ϩ mice (Fig. 3B ).
Taken together, these results ( Fig. 1 to 3 ) indicate that the degree of virulence was S2308 Ͼ S19 Ͼ RB51, as determined by CFU from the livers and spleens of IRF-1 Ϫ/Ϫ mice. Also, virulence as determined by CFU correlated with the rapidity of death of infected IRF-1 Ϫ/Ϫ mice in the order of S2308 Ͼ S19 Ͼ RB51.
Histologic and phenotypic analysis of Brucella-infected IRF-1 ؊/؊ and IRF-1 ؉/؉ mice. Brucellosis induces chronic granuloma formation in the livers and spleens of humans and mice (5, 15a, 17) . To determine whether pathologic changes could be detected with different strains of Brucella, IRF-1 Ϫ/Ϫ and IRF-1 ϩ/ϩ mice were infected with 5 ϫ 10 5 CFU of S2308 or RB51. Mice were killed at day 12, tissues were histologically examined, and consistent changes were noted in the livers. S2308 induced more granulomas in the livers of IRF-1 Ϫ/Ϫ and IRF-1 ϩ/ϩ mice than RB51 did (Fig. 4) . Further, more extensive multifocal granulomas were detected in IRF-1 Ϫ/Ϫ mice compared to IRF-1 ϩ/ϩ mice (Fig. 4) . These findings in IRF-1 Ϫ/Ϫ mice indicate that the extent of liver damage caused by a B. abortus strain correlates with the hepatic CFU burden of B. abortus. Histologic analysis of brain, lung, heart, kidney, spleen, genital, and gastrointestinal organs did not indicate significant or consistent changes in these organs.
Interestingly, infected moribund IRF-1 Ϫ/Ϫ mice possessed a very unique phenotype visually discernible from healthy, infected IRF-1 Ϫ/Ϫ mice (Fig. 5) . IRF-1 Ϫ/Ϫ mice infected with B. abortus S2308 or S19 at 5 ϫ 10 5 CFU contained 6 to 10 ml of ascitic fluid, whereas the RB51 infected IRF-1 Ϫ/Ϫ mice did not. These findings in IRF-1 Ϫ/Ϫ mice suggest that virulent Brucella infection causes hepatic damage, leading to ascites production, and the acquisition of ascitic fluid could be a key clinical sign to detect the level of virulence in Brucella strains. Ϫ/Ϫ mice (n ϭ 11 per group) to B. abortus (5 ϫ 10 5 CFU) S2308, S19, and RB51. Each symbol represents a day. IRF-1 Ϫ/Ϫ mice infected with RB51 survived longer than S2308 (P Ͻ 0.0001)-or S19 (P Ͻ 0.0001)-infected mice. Mice infected with S19 survived longer than S2308 (P Ͻ 0.005)-infected mice.
FIG. 2. Infection of IRF-1
ϩ/ϩ mice with 5 ϫ 10 5 CFU of S2308, S19, and RB51. Five IRF-1 ϩ/ϩ mice were used for each time per group for the enumeration of splenic Brucella CFU. Ϫ/Ϫ mice, but the cbp mutant produced two deaths from 11 infected mice after 20 days postinoculation (Fig. 6A) . Thus, the degree of attenuation in the cbp mutant was not sufficient to prevent the death of IRF-1 Ϫ/Ϫ mice. In IRF-1 Ϫ/Ϫ mice, bap mutants induced death in 50% of the mice 12 days after infection (Fig. 6A ) compared to S2308 infection that induced the death of 50% of IRF-1 Ϫ/Ϫ mice at 10 days. However, this discrepancy was not statistically significant.
Taken together, these results indicate that IRF-1 Ϫ/Ϫ mice infected with cyd or cbp mutants survived longer than when infected with S2308 (P Ͻ 0.0001). IRF-1 Ϫ/Ϫ mice infected with the bap mutant survived as long as mice infected with S2308. Thus, the level of virulence from Brucella mutants, as reflected in CFU in the spleens of IRF-1 ϩ/ϩ mice, is compatible with virulence as defined by the rapidity of death in IRF-1 Ϫ/Ϫ mice infected with 5 ϫ 10 5 CFU of S2308, S19, or RB51. (Fig. 3) . To determine the clearance of cyd, cbp, and bap S2308 mutants from mice, splenic B. abortus CFU were first counted from IRF-1 ϩ/ϩ mice after infection with these mutants at 5 ϫ 10 5 CFU (Fig. 6B) . The cyd gene-interrupted mutant was rarely detected in spleens after 2 weeks postinfection from the spleens. CFU detected from mice infected with the cbp geneinterrupted mutant had a 1-log difference compared to S2308-infected mice during the 4 weeks of infection. The parental S2308 and cbp mutant had statistically different (P Ͻ 0.05) CFU at all weeks examined (Fig. 6B) . In contrast to cyd and cbp mutants, no significant difference in CFU of bacteria from spleens was detected between the bap mutant and its parental strain during the 4 weeks of infection in IRF-1 ϩ/ϩ mice. Thus, the apparent order of virulence detected by splenic CFU in IRF-1 ϩ/ϩ mice was S2308 ϭ bap Ͼ cbp Ͼ cyd ϭ RB51. To determine whether hepatic damage from bap, cbp, and cyd mutants correlated with the criteria for virulence with S2308, S19, and RB51 in IRF-1 Ϫ/Ϫ mice, IRF-1 Ϫ/Ϫ and IRF-1 ϩ/ϩ mice were infected with these mutants, and Brucella CFU were enumerated from livers ( Fig. 7A) and spleens (Fig. 7B ) at the moribund stage or 4 weeks after infection. Twelve days after bap mutant injection, a 3.5-log CFU difference in livers and a 1-log CFU difference in spleens was detected between IRF-1 ϩ/ϩ and IRF-1 Ϫ/Ϫ mice. These results coincide with results in Fig. 3 with S2308-infected IRF-1 ϩ/ϩ and IRF-1 Ϫ/Ϫ mice, confirming that hepatic bacterial burden correlates with the death of IRF-1 Ϫ/Ϫ mice. At 4 weeks after cbp mutant injection, 4 logs of bacterial CFU were detected in the livers of IRF-1 Ϫ/Ϫ mice, whereas no B. abortus were detected from the livers of IRF-1 ϩ/ϩ mice (Fig. 7A) , suggesting that residual basal immunity in IRF-1 Ϫ/Ϫ mice may control cbp infection. Additionally, a 2-log CFU difference in the cbp mutant was detected from the spleens of IRF-1 ϩ/ϩ and IRF-1 Ϫ/Ϫ mice (Fig. 7B) . The hepatic bacterial burden induced by cbp mutants in IRF-1 Ϫ/Ϫ mice at 4 weeks after infection was 3 logs less than the CFU detected from bap-or S2308-infected IRF-1 Ϫ/Ϫ mice at the moribund stage. No cyd mutant was detected from the livers or spleens of IRF-1 ϩ/ϩ or IRF-1 Ϫ/Ϫ mice at 4 weeks after infection. Therefore, these results support a correlation between hepatic bacterial burden and the death of IRF-1 Ϫ/Ϫ mice and suggest that a level of virulence equivalent to that of S2308 is required to produce death in IRF-1 Ϫ/Ϫ mice.
Biochemical analysis of hepatic damage in IRF-1
؊/؊ mice. The existence of ascitic fluid (Fig. 5) , as well as the hepatic bacterial burden in IRF-1 Ϫ/Ϫ mice infected with virulent Brucella strains (Fig. 6A) , suggests progression of liver damage. Because livers from IRF-1 Ϫ/Ϫ mice infected with B. abortus strain S2308 had marked granulomas (Fig. 4) , GOT, GPT, and albumin concentrations in sera were measured to quantify the level of hepatic damage at the moribund stage or 4 weeks postinoculation (Fig. 8) . Both uninfected IRF-1 ϩ/ϩ and IRF-1 Ϫ/Ϫ mice maintained a normal GOT and GPT activity in serum (37 and 19 IU/liter, respectively [data not shown]) (23) . Also, IRF-1 ϩ/ϩ and IRF-1 Ϫ/Ϫ mice infected with cyd mutants did not have increased GOT and GPT activities in sera at 4 weeks postinoculation. In contrast, bap-and cbp-infected IRF-1 ϩ/ϩ and IRF-1 Ϫ/Ϫ mice possessed increased GOT (Fig. 8A ) and GPT (Fig. 8B ) activities at the moribund stage, indicating that acute hepatitis occurred in both mouse strains. However, the extent of liver damage between the two mouse strains was evident with a twofold increase in IRF-1 ϩ/ϩ mice and a fourfold-increased GOT and GPT levels in IRF-1 Ϫ/Ϫ mice. These results suggest that 4 weeks of cbp mutant infection generates hepatic damage similar to that induced by S2308 (Fig. 3 and 4) or bap mutants at 12 days postinoculation, suggesting that the death of cbp-infected IRF-1 Ϫ/Ϫ mice may occur after 4 weeks postinoculation. In fact, two more mice were dead after the 
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Brucella dose-and virulence-dependent protection in immunized IRF-1 ؊/؊ mice. IRF-1 Ϫ/Ϫ mice were immunized with selected Brucella strains at sublethal doses for 6 weeks and challenged with the lethal dose (5 ϫ 10 5 CFU) of S2308. All IRF-1 Ϫ/Ϫ mice immunized with any Brucella strain survived longer than nonimmunized IRF-1 Ϫ/Ϫ mice, suggesting that immunological memory exists and can provide protection (Table 2). In addition, two major results were noticed. First, in terms of Brucella strains possessing the same level of virulence, higher doses of immunization provide better protection. For example, IRF-1 Ϫ/Ϫ mice immunized with RB51 or cyd mutants at 5 ϫ 10 7 CFU provided twofold greater protection than mice immunized with 5 ϫ 10 5 CFU. Second, the more attenuated the Brucella strain, the higher the dose of immunization required to provide protection. For instance, IRF-1 Ϫ/Ϫ mice immunized with S19 at 5 ϫ 10 3 CFU provided similar protection to IRF-1 Ϫ/Ϫ mice immunized with RB51 or cyd mutants at 5 ϫ 10 7 CFU. These results indicate that IRF-1 Ϫ/Ϫ mice maintain an adaptive immunological memory necessary for protection, and protection in IRF-1 Ϫ/Ϫ mice is dependent on the level of bacterial virulence and the dose of immunization.
DISCUSSION
Human brucellosis is a chronic, undulating disease, and currently there is no human vaccine. Thus, there is a need to rank the virulence of mutant Brucella that might serve as potential vaccine candidates. Mice have been used to determine Brucella virulence since the chronic nature of Brucella infection in mice parallels the chronic nature of human infection (3, 20) . However, such studies are complicated by the need to monitor bacterial clearance from organs for at least 6 weeks, requiring large numbers of mice to frequently sample for bacteria, and such experiments are labor-intensive. Therefore, animal models that provide a rapid measure of Brucella virulence are needed.
The IRF-1 Ϫ/Ϫ mouse provides a useful set of three criteria used to define virulence in brucellosis; these are summarized in Table 1 . First, the day when 50% of IRF-1 Ϫ/Ϫ mice die after injection of 5 ϫ 10 5 CFU of bacteria is an important indication of virulence. The more rapidly the death occurs, the greater the bacterial virulence. Second, the extent of liver damage, e.g., the presence of granulomas, the liver transaminase activity, and the hepatic CFU bacterial count supports the virulence of the Brucella strain. Third, the minimum immunizing dose for protection against challenge with virulent S2308 (5 ϫ 10 (Fig. 1 ) and bacterial clearance from organs (Fig. 2) . Second, using genetically identified bap, cbp, and cyd B. abortus mutants containing distinctive levels of persistence in vitro (15) and in vivo (9, 15) , the application of IRF-1 Ϫ/Ϫ mice to detect virulence was tested (Fig. 4) . Third, the correlation between the level of virulence and the level of hepatic damage was determined by measuring the hepatic bacterial CFU and transaminase activities, as well as the albumin concentration in serum at either the moribund stage or 4 weeks postinoculation, suggesting that death in IRF-1 Ϫ/Ϫ mice is associated with hepatic damage (Fig. 3, 5, and 6 ). Together, these results suggest that the level of Brucella virulence can be determined by IRF-1 Ϫ/Ϫ mouse survival and that the level of Brucella virulence correlates with bacterial CFU and level of hepatic damage, as reflected by transaminase and albumin levels in serum.
One manifestation of human brucellosis is acute hepatitis (8, 17) . Most human beings or animals infected with Brucella overcome this acute hepatitis and maintain a chronic infection, and this transition is dependent on the virulence of Brucella strains and the induction of an adaptive immune response (4, 17) . However, in some cases, human brucellosis results in death. For example, humans with Brucella peritonitis and liver problems, such as alcoholism or hepatitis virus infection, contain ascites and can die if proper treatment does not follow (1, 5, 22, 30) . Similarly, in IRF-1 Ϫ/Ϫ mice in which hepatitis occurs in the absence of important adaptive immune components, animals infected with virulent strain 2308 are unable to control infection. IRF-1 Ϫ/Ϫ mice infected with the virulent strain died within 12 days, supporting the role of IRF-1 as essential for host immunity to Brucella; however, the defective immune components in IRF-1 Ϫ/Ϫ mice that contribute to Brucella susceptibility are unknown. In IRF-1 Ϫ/Ϫ mice, the host immune mechanisms that fail to control hepatic damage caused by virulent Brucella require further experiments.
In contrast to lethality when IRF-1 Ϫ/Ϫ mice were infected with Brucella S2308, IRF-1 Ϫ/Ϫ mice infected with attenuated Brucella strains did not die, supporting the possibility that IRF-1 Ϫ/Ϫ mice have a level of adaptive immunity that may protect these mice. Additional studies are required to confirm the relationship between Brucella virulence and dose-dependent immune protection in IRF-1 Ϫ/Ϫ mice. Survival of IRF-1 Ϫ/Ϫ mice was unexpected since this mouse strain is deficient in IL-12 p40 induction that is required for a Th1 immune response against many intracellular pathogens (18, 29) . We hypothesize Kupffer cells may not control virulent Brucella because the levels of IFN-␥ and TNF-␣ in IRF-1 Ϫ/Ϫ mice are lower than in wild-type mice (26) . Insufficient levels of IFN-␥ and TNF-␣ may not activate phagocytic activity of Kupffer cells, permitting continued B. abortus proliferation in the liver.
The death of IRF-1 Ϫ/Ϫ mice after virulent Brucella infection is a unique feature in brucellosis because even SCID (21) and nude (6) mice control Brucella infection. IRF-1 Ϫ/Ϫ mice are deficient in CD8 ϩ T cells and NK cells, as well as in the induction of IL-12, p40, and iNOS (18, 29) . This phenotypically well-characterized mouse strain has been used to investigate the role of IRF-1 or the role of defective immune components during infection. For example, IRF-1 Ϫ/Ϫ mice are susceptible to Mycobacterium bovis BCG (12), Leishmania major (16) , and Toxoplasma gondii (14) due to the absence of iNOS induction and/or IL-12 p40 induction but are resistant to Listeria monocytogenes (11) infection. The death of IRF-1 Ϫ/Ϫ mice infected with T. gondii has been reported previously, but the dose-and virulence-dependent death and the cause of death have not been investigated. Thus, the susceptibility of IRF-1 Ϫ/Ϫ mice appears to be pathogen specific.
IRF-1 Ϫ/Ϫ mice can serve as a useful animal for evaluating mutant brucellae. We have identified Brucella promoters and associated genes activated early in macrophage infection (10) . Now, using targeted gene disruption, IRF-1 Ϫ/Ϫ mice can be used to determine the association of these bacterial genes with virulence in the process of bacterial pathogenesis.
In summary, we have demonstrated that virulence can be defined by (i) the rapidity of death in IRF-1 Ϫ/Ϫ mice infected with 5 ϫ 10 5 CFU; (ii) the level of hepatic damage detected by the increased hepatic bacterial burden, as well as transaminase and albumin assays; and (iii) dose-dependent immune protection against virulent Brucella challenge can be engendered in IRF-1 Ϫ/Ϫ mice by attenuated Brucella strains. These results suggest that the application of IRF-1 Ϫ/Ϫ mice to brucellosis research will aid in the understanding of this host-pathogen interaction. Further, IRF-1 Ϫ/Ϫ mice, as an animal model, provide a rapid assessment of Brucella virulence that is useful for screening large numbers of Brucella strains. In addition, IRF-1 Ϫ/Ϫ mice will contribute to defining the adaptive immune components and molecular mechanisms of immunity required for protection. Defined criteria for virulence combined with a rapid screening mouse model, the IRF-1 Ϫ/Ϫ mouse, will facilitate the development of novel vaccines.
